Home
Independent Director
Whole Time Director & CFO
Company Sec. & Compli. Officer
Chairman & Managing Director
Whole-time Director
NSE: CONCORDDRUGS
Share Price
Date | Price (₹) |
---|---|
15 Jan 2025 | 35.59 |
14 Jan 2025 | 37.72 |
13 Jan 2025 | 36.83 |
10 Jan 2025 | 36.71 |
09 Jan 2025 | 37.87 |
08 Jan 2025 | 37.93 |
07 Jan 2025 | 37.62 |
06 Jan 2025 | 37.38 |
03 Jan 2025 | 38.46 |
02 Jan 2025 | 38.31 |
Market Cap
35 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
1.0
Day’s High
37.94
Day’s Low
35.1
DTE
0.6
ROE
-1.5
52 Week High
48.95
52 Week Low
30.59
ROCE
2.3
1M
1Y
3Y
5Y
Net profit of Concord Drugs declined 93.88% to Rs 0.03 crore in the quarter ended June 2024 as again
Read more
10 Aug 2024
Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 2024. Powered
Read more
06 Aug 2024
Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September 2024. Powe
Read more
03 Sep 2024
Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 Sept
Read more
19 Sep 2024